Related Experiment Videos

Interaction between Cdc37 and Cdk4 in human cells

L Lamphere1, F Fiore, X Xu

  • 1Mitotix, Inc., Cambridge, Massachusetts 02139, USA.

Oncogene
|April 24, 1997
PubMed

Insights

Researchers identified Cdc37 as a novel protein interacting with Cyclin-dependent kinase 4 (Cdk4). Cdc37 facilitates Cdk4/cyclin D1 complex assembly and competes with p16 for Cdk4 binding.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Protein Interactions

Background:

  • Cyclin-dependent kinases (Cdks) regulate cell cycle progression.
  • Cdk4, in complex with D-type cyclins, is a key regulator of the G1 to S phase transition.
  • Dysregulation of Cdk4 activity is implicated in various cancers.

Purpose of the Study:

  • To identify novel interacting partners of Cdk4.
  • To characterize the interaction between Cdk4 and its human homologue of yeast Drosophila CDC37 gene product, Cdc37.
  • To elucidate the functional role of Cdc37 in Cdk4/cyclin D1 complex formation and kinase activity.

Main Methods:

  • Yeast two-hybrid system for identifying protein-protein interactions.
  • In vitro kinase assays to assess Cdk4/cyclin D1 activity.
  • Co-immunoprecipitation to confirm protein binding.

Main Results:

  • The yeast two-hybrid system identified Cdc37 as a novel Cdk4 interacting protein.
  • Cdc37 specifically interacts with Cdk4 and Cdk6, but not other tested Cdks (Cdc2, Cdk2, Cdk3, Cdk5) or cyclins.
  • Cdc37 facilitates the assembly of Cdk4/cyclin D1 complexes in vitro.
  • Cdc37 competes with the inhibitor p16 for binding to Cdk4.

Conclusions:

  • Cdc37 is a novel binding partner of Cdk4 and Cdk6.
  • Cdc37 plays a role in facilitating Cdk4/cyclin D1 complex formation.
  • Cdc37 may be involved in the mechanism by which p16 inhibits Cdk4 activity by interfering with complex assembly.

Related Concept Videos